Navigation Links
Mindray Medical International Announces Second Quarter 2008 Results
Date:9/3/2008

RES

Three months ended June 30, Six months ended June 30

2007 2008 2007 2008

US$ US$ US$ US$

(unaudited) (unaudited) (unaudited) (unaudited)

(In thousands, except (In thousands, except

share and per share data) share and per share data)

Net revenues 73,032 145,667 127,476 233,095

Non-GAAP net income

(note 3) 22,752 35,205 40,749 63,031

Non-GAAP net margin 31.2% 24.2% 32.0% 27.0%

Expense/Amortization

of acquired

intangible assets (613) (9,833) (1,220) (10,490)

Deferred tax impact

related to acquired

intangible assets 92 1,035 183 1,153

Effect of change in

tax rate on

deferred tax -- -- -- --

Share-based

compensation (1,867) (2,350) (3,577) (4,585)

GAAP net income 20,363 24,057 36,135 49,109

GAAP net margin 27.9% 16.5% 28.3% 21.1%

Non-GAAP income per

share - basic 0.21 0.33 0.38 0.59

Non-GAAP income per

share - diluted 0.20 0.31 0.36 0.56

GAAP income per share

- basic 0.19 0.22 0.34 0.46

GAAP income per share

- diluted 0.18 0.21 0.32 0.43

Shares used in

computation of:

Basic earnings per

share 106,163,849 107,263,477 105,962,395 107,113,068

Diluted earn
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces First Quarter 2008 Results
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email: